{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT06312813",
            "orgStudyIdInfo": {
                "id": "2023-296"
            },
            "organization": {
                "fullName": "Wright State University",
                "class": "OTHER"
            },
            "briefTitle": "Evaluating Use of Topical Imipramine and Amitriptyline in Reducing Ultraviolet B Light-Induced Redness in Patients With Rosacea",
            "officialTitle": "Pilot Studies Evaluating Use of Topical Imipramine and Amitriptyline in Reducing Ultraviolet B Light-Induced Redness in Patients With Rosacea",
            "therapeuticArea": [
                "Other"
            ],
            "study": "evaluating-use-of-topical-imipramine-and-amitriptyline-in-reducing-ultraviolet-b-light-induced-redness-in-patients-with-rosacea"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-03",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2024-02-27",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2028-12",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2028-12",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2024-03-08",
            "studyFirstSubmitQcDate": "2024-03-08",
            "studyFirstPostDateStruct": {
                "date": "2024-03-15",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-03-08",
            "lastUpdatePostDateStruct": {
                "date": "2024-03-15",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "Wright State University",
                "class": "OTHER"
            }
        },
        "oversightModule": {
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false,
            "isUsExport": true
        },
        "descriptionModule": {
            "briefSummary": "Rosacea is a common skin condition associated with easy blushing and red face; many patients with rosacea react to sunlight with increased redness. The purpose of this study is to determine if the use of a topical medication will help reduce sunlight induced redness and irritation in patients with rosacea."
        },
        "conditionsModule": {
            "conditions": [
                "Rosacea"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE2"
            ],
            "designInfo": {
                "allocation": "RANDOMIZED",
                "interventionModel": "PARALLEL",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "DOUBLE",
                    "whoMasked": [
                        "PARTICIPANT",
                        "INVESTIGATOR"
                    ]
                }
            },
            "enrollmentInfo": {
                "count": 48,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Imipramine and Vehicle",
                    "type": "EXPERIMENTAL",
                    "description": "4% imipramine and vehicle are applied on a 2x2cm2 area of the subject's cheek. The imipramine is applied on one side of the subject's face (cheek) and vehicle is applied on the other side.",
                    "interventionNames": [
                        "Drug: Imipramine",
                        "Drug: Vehicle"
                    ]
                },
                {
                    "label": "Amitriptyline and Vehicle",
                    "type": "EXPERIMENTAL",
                    "description": "4% amitriptyline and vehicle are applied on a 2x2cm2 area of the subject's cheek. The amitriptyline is applied on side of the subject's face (cheek) and vehicle is applied on the other side.",
                    "interventionNames": [
                        "Drug: Amitriptyline",
                        "Drug: Vehicle"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DRUG",
                    "name": "Imipramine",
                    "description": "4% imipramine",
                    "armGroupLabels": [
                        "Imipramine and Vehicle"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Amitriptyline",
                    "description": "4% amitriptyline",
                    "armGroupLabels": [
                        "Amitriptyline and Vehicle"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Vehicle",
                    "description": "0.1ml propylene glycol",
                    "armGroupLabels": [
                        "Amitriptyline and Vehicle",
                        "Imipramine and Vehicle"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Ultraviolet B induced erythema change with 4% imipramine",
                    "description": "Erythema change from baseline with 4% imipramine application in response to a low level of UVB are measured by using a mexameter device and thermal photography.",
                    "timeFrame": "10 minutes post-treatment"
                },
                {
                    "measure": "Ultraviolet B induced erythema change with 4% imipramine",
                    "description": "Erythema change from baseline with 4% imipramine application in response to a low level of UVB are measured by using a mexameter device and thermal photography.",
                    "timeFrame": "60 minutes post-treatment"
                },
                {
                    "measure": "Ultraviolet B induced erythema change with 4% imipramine",
                    "description": "Erythema change from baseline with 4% imipramine application in response to a low level of UVB are measured by using a mexameter device and thermal photography.",
                    "timeFrame": "120 minutes post-treatment"
                },
                {
                    "measure": "Ultraviolet B induced erythema change with 4% imipramine",
                    "description": "Erythema change from baseline with 4% imipramine application in response to a low level of UVB are measured by using a mexameter device and thermal photography.",
                    "timeFrame": "24 hours post-treatment"
                },
                {
                    "measure": "Ultraviolet B induced erythema change with 4% amitriptyline",
                    "description": "Erythema change from baseline with 4% amitriptyline application in response to a low level of UVB are measured by using a mexameter device and thermal photography.",
                    "timeFrame": "10 minutes post-treatment"
                },
                {
                    "measure": "Ultraviolet B induced erythema change with 4% amitriptyline",
                    "description": "Erythema change from baseline with 4% amitriptyline application in response to a low level of UVB are measured by using a mexameter device and thermal photography.",
                    "timeFrame": "60 minutes post-treatment"
                },
                {
                    "measure": "Ultraviolet B induced erythema change with 4% amitriptyline",
                    "description": "Erythema change from baseline with 4% amitriptyline application in response to a low level of UVB are measured by using a mexameter device and thermal photography.",
                    "timeFrame": "120 minutes post-treatment"
                },
                {
                    "measure": "Ultraviolet B induced erythema change with 4% amitriptyline",
                    "description": "Erythema change from baseline with 4% amitriptyline application in response to a low level of UVB are measured by using a mexameter device and thermal photography.",
                    "timeFrame": "24 hours post-treatment"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Tolerability of 4% imipramine on facial skin",
                    "description": "The tolerability of 4% imipramine on facial skin at baseline/Day 1 compared to Day 2 is measured by the Visual Analog Scale for pain and itch.",
                    "timeFrame": "10 minutes post-treatment"
                },
                {
                    "measure": "Tolerability of 4% imipramine on facial skin",
                    "description": "The tolerability of 4% imipramine on facial skin at baseline/Day 1 compared to Day 2 is measured by the Visual Analog Scale for pain and itch.",
                    "timeFrame": "60 minutes post-treatment"
                },
                {
                    "measure": "Tolerability of 4% imipramine on facial skin",
                    "description": "The tolerability of 4% imipramine on facial skin at baseline/Day 1 compared to Day 2 is measured by the Visual Analog Scale for pain and itch.",
                    "timeFrame": "120 minutes post-treatment"
                },
                {
                    "measure": "Tolerability of 4% imipramine on facial skin",
                    "description": "The tolerability of 4% imipramine on facial skin at baseline/Day 1 compared to Day 2 is measured by the Visual Analog Scale for pain and itch.",
                    "timeFrame": "24 hours post-treatment"
                },
                {
                    "measure": "Tolerability of 4% amitriptyline on facial skin",
                    "description": "The tolerability of 4% amitriptyline on facial skin at baseline/Day 1 compared to Day 2 is measured by the Visual Analog Scale for pain and itch.",
                    "timeFrame": "10 minutes post-treatment"
                },
                {
                    "measure": "Tolerability of 4% amitriptyline on facial skin",
                    "description": "The tolerability of 4% amitriptyline on facial skin at baseline/Day 1 compared to Day 2 is measured by the Visual Analog Scale for pain and itch.",
                    "timeFrame": "60 minutes post-treatment"
                },
                {
                    "measure": "Tolerability of 4% amitriptyline on facial skin",
                    "description": "The tolerability of 4% amitriptyline on facial skin at baseline/Day 1 compared to Day 2 is measured by the Visual Analog Scale for pain and itch.",
                    "timeFrame": "120 minutes post-treatment"
                },
                {
                    "measure": "Tolerability of 4% amitriptyline on facial skin",
                    "description": "The tolerability of 4% amitriptyline on facial skin at baseline/Day 1 compared to Day 2 is measured by the Visual Analog Scale for pain and itch.",
                    "timeFrame": "24 hours post-treatment"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* Fitzpatrick Skin Type I - IIII\n* Self-identified rosacea or no history of flushing/blushing for controls\n* Able to provide medical history and list of medications -- control subjects will not be allowed to take medications that are known to be photosensitizers.\n\nExclusion Criteria:\n\n* Using imipramine, amitriptyline or any other tricyclic antidepressant (oral or topical)\n* Using topical anti-inflammatory (within 1 week) or systemic agents (e.g. prednisone)\n* Large tattoos in the designated testing areas\n* Tanning bed use within last 3 months\n* Photodynamic Therapy or UCB treatments in past 3 months\n* Female Subjects: pregnant or nursing",
            "healthyVolunteers": true,
            "sex": "ALL",
            "minimumAge": "18 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Manager Clinical Research Operations",
                    "role": "CONTACT",
                    "phone": "(937)-245-7500",
                    "email": "pturesearch@wrightstatephysicians.org"
                }
            ],
            "locations": [
                {
                    "facility": "Wright State Physicians",
                    "status": "RECRUITING",
                    "city": "Fairborn",
                    "state": "Ohio",
                    "zip": "45324",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Pharmacology Translational Unit",
                            "role": "CONTACT",
                            "phone": "937-245-7500",
                            "email": "pturesearch@wrightstatephysicians.org"
                        },
                        {
                            "name": "Travers",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 39.82089,
                        "lon": -84.01938
                    }
                }
            ]
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000012393",
                    "term": "Rosacea"
                }
            ],
            "ancestors": [
                {
                    "id": "D000012871",
                    "term": "Skin Diseases"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M8044",
                    "name": "Erythema",
                    "relevance": "LOW"
                },
                {
                    "id": "M15214",
                    "name": "Rosacea",
                    "asFound": "Rosacea",
                    "relevance": "HIGH"
                },
                {
                    "id": "M15674",
                    "name": "Skin Diseases",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC17",
                    "name": "Skin and Connective Tissue Diseases"
                },
                {
                    "abbrev": "BC23",
                    "name": "Symptoms and General Pathology"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                }
            ]
        },
        "interventionBrowseModule": {
            "meshes": [
                {
                    "id": "D000000639",
                    "term": "Amitriptyline"
                },
                {
                    "id": "D000007099",
                    "term": "Imipramine"
                }
            ],
            "ancestors": [
                {
                    "id": "D000000929",
                    "term": "Antidepressive Agents, Tricyclic"
                },
                {
                    "id": "D000000928",
                    "term": "Antidepressive Agents"
                },
                {
                    "id": "D000011619",
                    "term": "Psychotropic Drugs"
                },
                {
                    "id": "D000018712",
                    "term": "Analgesics, Non-Narcotic"
                },
                {
                    "id": "D000000700",
                    "term": "Analgesics"
                },
                {
                    "id": "D000018689",
                    "term": "Sensory System Agents"
                },
                {
                    "id": "D000018373",
                    "term": "Peripheral Nervous System Agents"
                },
                {
                    "id": "D000045505",
                    "term": "Physiological Effects of Drugs"
                },
                {
                    "id": "D000018759",
                    "term": "Adrenergic Uptake Inhibitors"
                },
                {
                    "id": "D000014179",
                    "term": "Neurotransmitter Uptake Inhibitors"
                },
                {
                    "id": "D000049990",
                    "term": "Membrane Transport Modulators"
                },
                {
                    "id": "D000045504",
                    "term": "Molecular Mechanisms of Pharmacological Action"
                },
                {
                    "id": "D000018663",
                    "term": "Adrenergic Agents"
                },
                {
                    "id": "D000018377",
                    "term": "Neurotransmitter Agents"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M3977",
                    "name": "Amitriptyline",
                    "asFound": "Transducer",
                    "relevance": "HIGH"
                },
                {
                    "id": "M10147",
                    "name": "Imipramine",
                    "asFound": "Epicondylitis",
                    "relevance": "HIGH"
                },
                {
                    "id": "M4247",
                    "name": "Antidepressive Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M4248",
                    "name": "Antidepressive Agents, Tricyclic",
                    "relevance": "LOW"
                },
                {
                    "id": "M14474",
                    "name": "Psychotropic Drugs",
                    "relevance": "LOW"
                },
                {
                    "id": "M4032",
                    "name": "Analgesics",
                    "relevance": "LOW"
                },
                {
                    "id": "M20786",
                    "name": "Analgesics, Non-Narcotic",
                    "relevance": "LOW"
                },
                {
                    "id": "M20746",
                    "name": "Adrenergic Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M20504",
                    "name": "Neurotransmitter Agents",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "Analg",
                    "name": "Analgesics"
                },
                {
                    "abbrev": "PsychDr",
                    "name": "Psychotropic Drugs"
                },
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                }
            ]
        }
    },
    "hasResults": false
}